Capital Impact Advisors’s NRC Health Common Stock NRC Stock Holding History

Capital Impact Advisors’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,917	Closed	-$685K	–	115
2020 Q3	$685K	Hold	13,917	–	–	0.2%	106
2020 Q2	$810K	Hold	13,917	–	–	0.27%	105
2020 Q1	$633K	Buy	13,917 +1,604	+13%	+$96.4K	0.27%	103
2019 Q4	$812K	Hold	12,313	–	–	0.29%	113
2019 Q3	$710K	Hold	12,313	–	–	0.27%	118
2019 Q2	$681K	Buy	+12,313	New	+$570K	0.25%	125
2018 Q2	–	Sell	-41,476	Closed	-$1.21M	–	127
2018 Q1	$1.21M	Buy	41,476 +5,411	+15%	+$182K	0.5%	110
2017 Q4	$1.34M	Hold	36,065	–	–	0.58%	84
2017 Q3	$1.36M	Buy	36,065 +6,040	+20%	+$190K	0.61%	79
2017 Q2	$808K	Sell	30,025 -11,502	-28%	-$281K	0.37%	138
2017 Q1	$818K	Buy	41,527 +5,840	+16%	+$108K	0.33%	149
2016 Q4	$678K	Hold	35,687	–	–	0.28%	188
2016 Q3	$581K	Hold	35,687	–	–	0.25%	198
2016 Q2	$489K	Hold	35,687	–	–	0.23%	206
2016 Q1	$555K	Buy	35,687 +8,558	+32%	+$125K	0.26%	194
2015 Q4	$435K	Hold	27,129	–	–	0.21%	209
2015 Q3	$324K	Hold	27,129	–	–	0.16%	202
2015 Q2	$386K	Hold	27,129	–	–	0.18%	218
2015 Q1	$391K	Buy	+27,129	New	+$383K	0.18%	213

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Impact Advisors's NRC Position: Q4 2020 in Review

Capital Impact Advisors sold out of NRC Health Common Stock (NRC) in Q4 2020, closing a stake of 13,917 shares — an estimated $685K sold.

Capital Impact Advisors first reported a position in NRC in Q1 2015 and held it in 19 quarters. The position peaked at $1.36M in Q3 2017. 94 funds tracked by Wall St. Rank hold NRC as of Q4 2020.

Capital Impact Advisors reported no remaining NRC Health Common Stock position as of Q4 2020 after selling out during the quarter.
Capital Impact Advisors sold 13,917 NRC Health Common Stock shares in Q4 2020, an estimated $685K.
Capital Impact Advisors first reported a position in NRC Health Common Stock in Q1 2015 and held it in 19 quarters.
Capital Impact Advisors's NRC Health Common Stock position peaked at $1.36M in Q3 2017.
94 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2020.

Based on Capital Impact Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.